BeOne Medicines Expects 2026 Revenue of $6.9B to $7.0B
BeOne Medicines expects 2026 revenue of $6.9B to $7.0B, versus the FactSet estimate of $6.78B; no catalyst was supplied.
BeOne Medicines expects 2026 revenue of $6.9B to $7.0B, versus the FactSet estimate of $6.78B; no catalyst was supplied.